DCN and skin disorder: DCN exhibits both anti-angiogenic and anti-fibrotic properties, and previous studies have shown that genetic deletion or pharmacological inhibition of GzmB can prevent DCN cleavage and increase DCN levels in several skin disorders [12, 13].